Neuroenhancement

Unlocking Evidence-Based Ingredients for Active Nutrition, Executive Function, eSports and Optimal Lifespan, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, May 9, 2024
Nutrition, Lutein, Xanthophyll, Siderian, Neuroenhancement, Visual perception, Business, Attention, Exercise, Science, Athlete, Nutrient, Function (mathematics), Quality of life, Longevity, Dietary supplement

TORONTO, May 9, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar focusing on the effect of cognitive aspects like mental processing, executive function and cognitive reasoning across eSports, active nutrition and lifespan optimization, and the critical role played by them in human performance and well-being.

Key Points: 
  • In this free webinar, attendees will gain insights into how active nutrition helps athletes, gamers and professionals attain optimal cognitive performance.
  • Incorporating these scientifically validated ingredients into dietary formulations can provide tangible benefits for consumers striving for peak cognitive performance.
  • In summary, the scientific evidence highlights the interconnectedness of cognitive aspects across eSports, active nutrition and lifespan optimization.
  • Register for this webinar today to understand how active nutrition helps athletes, gamers and professionals attain optimal cognitive performance.

Resonance Health to Unveil Innovative Mushroom Extracts at Microdose Wonderland Convention in Miami

Retrieved on: 
Monday, November 6, 2023
Neuroenhancement, Grain, Immune system, Resonance, Mycelium, Longevity, Medical imaging, Dietary supplement

Miami, Florida--(Newsfile Corp. - November 6, 2023) - Resonance Health, a burgeoning newcomer in the wellness industry, is excited to announce its participation in the forthcoming Microdose Wonderland Convention, taking place from November 9th to November 11th in Miami.

Key Points: 
  • Miami, Florida--(Newsfile Corp. - November 6, 2023) - Resonance Health, a burgeoning newcomer in the wellness industry, is excited to announce its participation in the forthcoming Microdose Wonderland Convention, taking place from November 9th to November 11th in Miami.
  • This event will serve as a pivotal platform for Resonance Health to introduce their innovative approach to premium mushroom extracts, setting the stage for their official product launch in February 2024.
  • The Microdose Wonderland Convention is a unique gathering that will bring together industry leaders, psychedelic experts, and thought leaders for a series of workshops and panels.
  • As a new entrant in the wellness industry, Resonance Health is eager to present their vision to the wider community of wellness enthusiasts at the Microdose Wonderland Convention.

Natural Stacks Appoints Dr. Michael Lewis as Scientific Advisor, Expanding Commitment to Brain Health and Cognitive Research

Retrieved on: 
Monday, October 23, 2023
Knowledge, Neuroenhancement, American College, Neuro, Treatment, American College of Preventive Medicine, Neuroprotection, Research, Private practice, Brain, Retirement, American Nutrition Association, Concussion, Brain damage, Patient, Nutrient, Cognition, Longevity, Medical device, Medical imaging, MD

SEATTLE, Oct. 23, 2023 /PRNewswire-PRWeb/ -- Natural Stacks, a leading innovator in brain health supplements and cognitive enhancement, is thrilled to appoint Dr. Michael Lewis, MD as their esteemed Scientific Advisor.

Key Points: 
  • Natural Stacks, a leading innovator in brain health supplements and cognitive enhancement, is thrilled to appoint Dr. Michael Lewis, MD as their esteemed Scientific Advisor.
  • SEATTLE, Oct. 23, 2023 /PRNewswire-PRWeb/ -- Natural Stacks, a leading innovator in brain health supplements and cognitive enhancement, is thrilled to appoint Dr. Michael Lewis, MD as their esteemed Scientific Advisor.
  • Dr. Lewis is a distinguished figure in the field of brain health, cognition, and brain trauma.
  • Dr. Lewis's role as Scientific Advisor will involve collaborating with Natural Stacks' research and development teams to explore groundbreaking insights in brain health and nutrition.

MyPEAK, Organic Muscle, SRW, and PaleoPro Named Best Companies for Fast-Paced Growth by News7Health

Retrieved on: 
Tuesday, November 15, 2022
Thompson, Growth, Movement, Health, Population, USDA, Awareness, NEW, Industry, Research, Neuroenhancement, Dietary supplement, Brilliance

NEW YORK, Nov. 15, 2022 /PRNewswire/ -- Gerald Thompson, a news editor for News7Health Corp. announced this morning that four particularly entrepreneurial and innovative providers of nutritional supplement products have been named the best in their class based upon their respective consumer reviews and product research conducted by News7Health. (For Full Version of This Release)

Key Points: 
  • News7Health has named four nutritional supplement and nootropics providers as highly-promising industry disruptors whose anticipated growth is slated to outpace that of their more established competitors and counterparts in the consumer marketplace.
  • NEW YORK, Nov. 15, 2022 /PRNewswire/ -- Gerald Thompson, a news editor for News7Health Corp. announced this morning that four particularly entrepreneurial and innovative providers of nutritional supplement products have been named the best in their class based upon their respective consumer reviews and product research conducted by News7Health.
  • News7Health Corp. produces a digital publication providing vital news, current stories and interesting interviews about health-related matters to its readership.
  • Its content is updated continuously as stories develop and as important new information becomes available.

Brazilian Sports Nutrition Market Report (2022 to 2030) - Featuring PepsiCo, MusclePharm, Glanbia and Max Titanium Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, September 30, 2022
Fitness & Nutrition, Health, Adult, Adoption, Health, Traction, Athlete, COVID-19, Risk, Prevalence, Nutrition, Growth, Hypertension, Immunity, Diabetes, Satellite dish, Quality of life, Sport, Heat cramps, Neuroenhancement, Awareness, Man, Fatigue, CAGR, Dietary supplement, Speciality chemicals, Obesity

This, in turn, has increased the adoption of various supplements including sports nutrition products.

Key Points: 
  • This, in turn, has increased the adoption of various supplements including sports nutrition products.
  • According to a report COVID-19 and Obesity: The 2021 Atlas, the prevalence of obesity in men is estimated to reach 25.2% by 2025 in Brazil.
  • Gym-goers and fitness enthusiasts consume sports nutrition products for various benefits such as delaying fatigue, improving strength, and reducing the risk of heat cramps.
  • Manufacturers operating in the Brazil sports nutrition space are offering innovative products to their consumers to increase product adoption and penetration.

Vaga.org Announces Merger with Vagarights.com: Enhancing the Online Experience Around Nootropics Research and Reviews

Retrieved on: 
Wednesday, February 2, 2022
VAGA, Neuroenhancement, Outline, Biotechnology, Research, Publishing, Health, GLOBE, News, Industry, Review, Retail, Risk management, Typesetting, Online shopping, Dietary supplement

Renowned for their leading nootropics supplement reviews, biohacking news and biotechnology research, both carry the VAGA brand and are considered to be leaders in this space.

Key Points: 
  • Renowned for their leading nootropics supplement reviews, biohacking news and biotechnology research, both carry the VAGA brand and are considered to be leaders in this space.
  • Brian Johnson, recognized as a leading expert on nootropics, sleep hacking and life span extension, will remain as lead editor.
  • With Brians help, VAGA nootropics research and reviews have become a trusted online resource, providing in-depth analysis on health and wellness supplements and techniques.
  • Vagarights is a popular nootropics and biohacking review and research website that provides scientifically accurate information in the form of reviews, news, analysis, thought pieces and offers.

Researchers boost human mental function with brain stimulation

Retrieved on: 
Monday, November 1, 2021
Program, Massachusetts General Hospital, Depression, MD, Research, University, University of Minnesota Medical School, Minneapolis–Saint Paul, Behavior, ARO, Anxiety, Self-control, Algorithm, List of Nature Research journals, Patient, Faculty, Food, MGH, Neuroenhancement, Intelligence, Medicine, Brain, Learning, National, Food and Drug Administration Amendments Act of 2007, Lists of diseases, Internal capsule, Psychiatry, Addiction, Deep brain stimulation, DARPA, Epilepsy, GLOBE, Doctor of Philosophy, Physician, Seizure, Medical device, Pharmaceutical industry, Medical imaging

PAUL, Nov. 01, 2021 (GLOBE NEWSWIRE) -- In a pilot human study, researchers from the University of Minnesota Medical School and Massachusetts General Hospital show it is possible to improve specific human brain functions related to self-control and mental flexibility by merging artificial intelligence with targeted electrical brain stimulation.

Key Points: 
  • PAUL, Nov. 01, 2021 (GLOBE NEWSWIRE) -- In a pilot human study, researchers from the University of Minnesota Medical School and Massachusetts General Hospital show it is possible to improve specific human brain functions related to self-control and mental flexibility by merging artificial intelligence with targeted electrical brain stimulation.
  • In this study, Widge collaborated with Massachusetts General Hospitals Sydney Cash, MD, PhD, an expert in epilepsy research; and Darin Dougherty, MD, an expert in clinical brain stimulation.
  • Together, they identified a brain region the internal capsule that improved patients mental function when stimulated with small amounts of electrical energy.
  • This system can read brain activity, decode from that when a patient is having difficulty, and apply a small burst of electrical stimulation to the brain to boost them past that difficulty, Widge said.

atai Life Sciences Announces Supportive Interim Data from First 8-Patient Cohort of Phase 2a Trial for Novel Treatment of Cognitive Impairment Associated with Schizophrenia

Retrieved on: 
Monday, November 1, 2021
Cognitive deficit, CIAS, Depression, Parkinson's disease, ERP, Technology, Volunteering, Entrepreneurship, United, Alzheimer's disease, Global Burden of Disease Study, Public expenditure, Anxiety, Memory, Private Securities Litigation Reform Act, GABA, List of life sciences, Disease, Education, U.S. Securities and Exchange Commission, SEC, Bipolar disorder, Disability, Delusion, Hallucination, Learning, Forward-looking statement, Cognition, Clinical trial, CEO, Biomarker, Addiction, Neuroenhancement, Science, Therapy, GLOBE, Doctor of Philosophy, Veni, vidi, vici, Government budget balance, Pharmaceutical industry

These early data have led atai to commit additional financial resources, enabling an accelerated clinical development timeline for RL-007, even ahead of completion of the ongoing Phase 2a trial.

Key Points: 
  • These early data have led atai to commit additional financial resources, enabling an accelerated clinical development timeline for RL-007, even ahead of completion of the ongoing Phase 2a trial.
  • With these data, from the interim analysis of the ongoing Phase 2a trial, we are encouraged to accelerate the overall development of RL-007 for CIAS, said Matthew Pando, PhD,CEOand Co-Founder ofRecognifyLife Science.
  • I would like to express my deepest gratitude to the patient volunteers who have supported our clinical trial thus far.
  • I believe that, with continued support, we have the potential to bring benefit to patients living with schizophrenia and its often very challenging cognitive impacts.

Aviv Scientific Raises $40 Million in Series B Funding to Create the World’s First High Dimensional OMICS Database of the Aging Process

Retrieved on: 
Wednesday, September 22, 2021
Health, Other Health, Other Science, Clinical Trials, Research, Science, Biotechnology, Longevity, Partnership, Medicine, Series, Therapy, OMICS, Ageing, HBOT, Fortis Healthcare, Life, Neuroenhancement, Biomarker, Phenotype, Entrepreneurship, Venture round, Technology, Human, Research, Movement, Genotype, Mechanics, Database, Shamir Medical Center, Pharmaceutical industry

Composed of longitudinal and comprehensive phenotype and genotype of normal and pathological adults, Aviv is currently developing an in-depth high dimensional OMICS database.

Key Points: 
  • Composed of longitudinal and comprehensive phenotype and genotype of normal and pathological adults, Aviv is currently developing an in-depth high dimensional OMICS database.
  • Aviv is playing a starring role in todays healthy aging movement, states Jonathan Preminger, Co-Founder and Chief Executive Officer of Aviv Scientific.
  • The new round of funding is a testament to our outstanding clinical outcomes, world-class team, strategic partnerships and cutting-edge technology.
  • Aviv intends to use the Series B funding to rapidly expand its global clinic footprint in the United States, Europe and Asia; grow its in-depth high dimensional OMICS database; bolster its technology and accelerate its medical research program.

Parisa Khosropour Joins Advisory Board of Neuroenhancement Lab, Inc.

Retrieved on: 
Thursday, February 25, 2021
Transhumanism, Neuroenhancement, Parisa, Suffern, New York, Alexander I. Poltorak

SUFFERN, N.Y., Feb. 25, 2021 /PRNewswire-PRWeb/ --Neuroenhancement Lab, Inc., a neuromodulation company headquartered in Suffern, NY, announced today that Parisa Khosropour Joined its Advisory Board.

Key Points: 
  • SUFFERN, N.Y., Feb. 25, 2021 /PRNewswire-PRWeb/ --Neuroenhancement Lab, Inc., a neuromodulation company headquartered in Suffern, NY, announced today that Parisa Khosropour Joined its Advisory Board.
  • "We are very pleased to welcome Parisa to our advisory board," said Dr. Alexander Poltorak, Neuroenhancement Lab's Founder and President.
  • "I have dedicated my career to improving the lives of patients through innovation," said Parisa khosropour.
  • "I am delighted to join the Advisory Board of Neuroenhancement Labs, utilizing cutting edge technology for the treatment of neurologic diseases."